Similar Items: Anti-tuberculosis drug design based on a possible mimicry between host and pathogen lipids
- Mycobacterial mycolic acids as immunoregulatory lipid antigens in the resistance to tuberculosis
- Mycobacterium tuberculosis persisters at the host-pathogen interface: development and application of tools for identification and elucidating impact on host response
- The host response to infection with pathogenic and non–pathogenic mycobacteria: a proteomics approach
- Characterisation of phenotypic and genotypic resistance to new and re-purposed tuberculosis drugs in the Western Cape, South Africa
- Evaluation of a radiometrically-determined regrowth model for the study of anti-tuberculosis drugs
- Elucidating the Smurf1- and other E3 ligase-mediated ubiquitination of mycobacterial proteins
Author: Verschoor, Jan Adrianus
- Amphotericin B as a mycolic acid specific targeting agent in tuberculosis
- Electrochemical impedance spectroscopy and surface plasmon resonance for diagnostic antibody detection
- Towards paper-based micro bio-sensing of biomarker anti-mycolic acid antibodies for TB diagnosis
- Chemically synthetic mycolic acids as vaccine adjuvants
- Towards a rapid immuno-test for tuberculosis: Immunochemical characterisation of a suitable mycolic acid antigen preparation
- Properties of anti-mycolic acid antibodies in human tuberculosis patients